These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24045598)

  • 1. Propafenone hepatotoxicity: report of a new case and review of the literature.
    Younan LB; Barada KA; Faraj WG; Tawil AN; Jabbour MN; Khoury MY; El-Majzoub NM; Eloubeidi MA
    Saudi J Gastroenterol; 2013; 19(5):235-7. PubMed ID: 24045598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propafenone hepatotoxicity: report of two new cases.
    Cocozzella D; Curciarello J; Corallini O; Olivera A; Alburquerque MM; Fraquelli E; Zamagna L; Olenchuck A; Cremona A
    Dig Dis Sci; 2003 Feb; 48(2):354-7. PubMed ID: 12643615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatic toxicity of propafenone: a case description].
    La Brocca A
    Ann Ital Med Int; 2002; 17(4):261-4. PubMed ID: 12532566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propafenone-induced liver injury: report of a case and review of the literature.
    Mondardini A; Pasquino P; Bernardi P; Aluffi E; Tartaglino B; Mazzucco G; Bonino F; Verme G; Negro F
    Gastroenterology; 1993 May; 104(5):1524-6. PubMed ID: 8482464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propafenone-related cholestatic hepatitis in an elderly patient.
    Grieco A; Forgione A; Giorgi A; Miele L; Gasbarrini G
    Ital Heart J; 2002 Jul; 3(7):431-4. PubMed ID: 12189974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acute cholestatic hepatitis caused by propafenone. Report of a case and review of the literature].
    Gandolfi A; Rota E; Zanghieri G; Tolomelli S; Bagnulo A; Mengoli M
    Recenti Prog Med; 2001 Mar; 92(3):197-9. PubMed ID: 11320851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revisiting propafenone toxicity.
    Alsaad AA; Ortiz Gonzalez Y; Austin CO; Kusumoto F
    BMJ Case Rep; 2017 Apr; 2017():. PubMed ID: 28446489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propafenone-induced drug fever in the absence of agranulocytosis.
    O'Rourke DJ; Palac RT; Holzberger PT; Gerling BR; Greenberg ML
    Clin Cardiol; 1997 Jul; 20(7):662-4. PubMed ID: 9220185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial flutter with 1:1 atrioventricular conduction caused by propafenone.
    el-Harari MB; Adams PC
    Pacing Clin Electrophysiol; 1998 Oct; 21(10):1999-2001. PubMed ID: 9793099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Persistent atrial flutter induced by propafenone (Rytmonorm)].
    Fazekas T; Kiss J; Pap I; Rudas L
    Orv Hetil; 1994 Aug; 135(33):1819-22. PubMed ID: 8072758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Liver function test impairment induced by propafenone in a 73 year old woman].
    Arinzon Z; Fridman R
    Harefuah; 2001 Nov; 140(11):1010-3, 1119. PubMed ID: 11759372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propafenone: an antiarrhythmic come in from the cold.
    Lancet; 1989 Dec 23-30; 2(8678-8679):1490-1. PubMed ID: 2574772
    [No Abstract]   [Full Text] [Related]  

  • 13. Placebo-controlled evaluations of propafenone for atrial tachyarrhythmias.
    Rae AP
    Am J Cardiol; 1998 Oct; 82(8A):59N-65N. PubMed ID: 9809902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and tolerability of long-term propafenone therapy for supraventricular tachyarrhythmias. The Propafenone Multicenter Study Group.
    Podrid PJ; Anderson JL
    Am J Cardiol; 1996 Aug; 78(4):430-4. PubMed ID: 8752188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propafenone associated severe central nervous system and cardiovascular toxicity due to mirtazapine: a case of severe drug interaction.
    Rajpurohit N; Aryal SR; Khan MA; Stys AT; Stys TP
    S D Med; 2014 Apr; 67(4):137-9. PubMed ID: 24791374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propafenone-induced torsade de pointes: cross-reactivity with quinidine.
    Hii JT; Wyse DG; Gillis AM; Cohen JM; Mitchell LB
    Pacing Clin Electrophysiol; 1991 Nov; 14(11 Pt 1):1568-70. PubMed ID: 1721143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical use of class IC antiarrhythmic drugs.
    Abi Samra F
    J La State Med Soc; 1989 May; 141(5):27-31. PubMed ID: 2499646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacogenetic study of the response to flecainide and propafenone in patients with atrial fibrillation].
    Martínez-Sellés M; Castillo I; Montenegro P; Martín ML; Almendral J; Sanjurjo M
    Rev Esp Cardiol; 2005 Jun; 58(6):745-8. PubMed ID: 15970126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group.
    Circulation; 1995 Nov; 92(9):2550-7. PubMed ID: 7586356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propafenone-induced ataxia: report of three cases.
    Odeh M; Seligmann H; Oliven A
    Am J Med Sci; 2000 Aug; 320(2):151-3. PubMed ID: 10981493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.